These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21689878)

  • 1. The impact of adding an extra dimension to a preference-based measure.
    Brazier J; Rowen D; Tsuchiya A; Yang Y; Young TA
    Soc Sci Med; 2011 Jul; 73(2):245-53. PubMed ID: 21689878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing and testing methods for deriving preference-based measures of health from condition-specific measures (and other patient-based measures of outcome).
    Brazier JE; Rowen D; Mavranezouli I; Tsuchiya A; Young T; Yang Y; Barkham M; Ibbotson R
    Health Technol Assess; 2012 Jul; 16(32):1-114. PubMed ID: 22832015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valuing Health Using Time Trade-Off and Discrete Choice Experiment Methods: Does Dimension Order Impact on Health State Values?
    Mulhern B; Shah K; Janssen MF; Longworth L; Ibbotson R
    Value Health; 2016; 19(2):210-7. PubMed ID: 27021755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of rasch analysis in reducing a large condition-specific instrument for preference valuation: the case of moving from AQLQ to AQL-5D.
    Young TA; Yang Y; Brazier JE; Tsuchiya A
    Med Decis Making; 2011; 31(1):195-210. PubMed ID: 20525959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States.
    Burström K; Teni FS; Gerdtham UG; Leidl R; Helgesson G; Rolfson O; Henriksson M
    Pharmacoeconomics; 2020 Aug; 38(8):839-856. PubMed ID: 32307663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of adding a sleep dimension to the EQ-5D descriptive system: a "bolt-on" experiment.
    Yang Y; Brazier J; Tsuchiya A
    Med Decis Making; 2014 Jan; 34(1):42-53. PubMed ID: 23525702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling a preference-based index for two condition-specific measures (asthma and overactive bladder) using a nonparametric Bayesian method.
    Kharroubi SA; Brazier JE; Yang Y
    Value Health; 2014 Jun; 17(4):406-15. PubMed ID: 24969001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the EQ-5D fit for purpose in asthma? Acceptability and content validity from the patient perspective.
    Whalley D; Globe G; Crawford R; Doward L; Tafesse E; Brazier J; Price D
    Health Qual Life Outcomes; 2018 Aug; 16(1):160. PubMed ID: 30075729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are condition-specific utilities more valid than generic preference-based ones in asthma? Evidence from a study comparing EQ-5D-3L and SF-6D with AQL-5D.
    Kontodimopoulos N; Stamatopoulou E; Brinia A; Talias MA; Ferreira LN
    Expert Rev Pharmacoecon Outcomes Res; 2018 Dec; 18(6):667-675. PubMed ID: 30048194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparatory study for the revaluation of the EQ-5D tariff: methodology report.
    Mulhern B; Bansback N; Brazier J; Buckingham K; Cairns J; Devlin N; Dolan P; Hole AR; Kavetsos G; Longworth L; Rowen D; Tsuchiya A
    Health Technol Assess; 2014 Feb; 18(12):vii-xxvi, 1-191. PubMed ID: 24568945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets.
    Law EH; Pickard AS; Xie F; Walton SM; Lee TA; Schwartz A
    Med Decis Making; 2018 Nov; 38(8):968-982. PubMed ID: 30403577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deriving a Preference-Based Measure for Myelofibrosis from the EORTC QLQ-C30 and the MF-SAF.
    Mukuria C; Rowen D; Brazier JE; Young TA; Nafees B
    Value Health; 2015 Sep; 18(6):846-55. PubMed ID: 26409613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing preference-based measures for diabetes: DHP-3D and DHP-5D.
    Mulhern B; Labeit A; Rowen D; Knowles E; Meadows K; Elliott J; Brazier J
    Diabet Med; 2017 Sep; 34(9):1264-1275. PubMed ID: 28477411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Condition-Specific Preference-Based Measures in Health Technology Assessment.
    Rowen D; Brazier J; Ara R; Azzabi Zouraq I
    Pharmacoeconomics; 2017 Dec; 35(Suppl 1):33-41. PubMed ID: 29052164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of methods for converting DCE values onto the full health-dead QALY scale.
    Rowen D; Brazier J; Van Hout B
    Med Decis Making; 2015 Apr; 35(3):328-40. PubMed ID: 25398621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
    Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
    Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of injured patient and general population valuations of EQ-5D health states for New Zealand.
    Wilson R; Hansen P; Langley J; Derrett S
    Health Qual Life Outcomes; 2014 Feb; 12():21. PubMed ID: 24548314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating a preference-based index for a 5-dimensional health state classification for asthma derived from the asthma quality of life questionnaire.
    Yang Y; Brazier JE; Tsuchiya A; Young TA
    Med Decis Making; 2011; 31(2):281-91. PubMed ID: 20924045
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.